The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1β in human chondrocytes

Journal of Orthopaedic Research

Volumn 31, Issue 4, 2013, Pages 531-537

  Matsushita, Takehiko ^a   Sasaki, Hiroshi ^a   Takayama, Koji ^a   Ishida, Kazunari ^a   Matsumoto, Tomoyuki ^a   Kubo, Seiji ^a   Matsuzaki, Tokio ^a   Nishida, Kotaro ^a   Kurosaka, Masahiro ^a   Kuroda, Ryosuke ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chondrocytes; IL 1 ; osteoarthritis; overexpression; SIRT1

Indexed keywords

AGGRECANASE 2; COLLAGENASE 3; INTERLEUKIN 1BETA; SIRTUIN 1; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ACETYLATION; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAM PROTEINS; CARTILAGE, ARTICULAR; CHONDROCYTES; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASES; OSTEOARTHRITIS; SIRTUIN 1; TRANSCRIPTION FACTOR RELA;

EID: 84874659060     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22268     Document Type: Article

References (26)

1. Goldring MB, Goldring SR., 2007. Osteoarthritis. J Cell Physiol 213: 626-634.
2. Lopez-Armada MJ, Carames B, Lires-Dean M, et al. 2006. Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthritis Cartilage 14: 660-669.
3. Daheshia M, Yao JQ., 2008. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol 35: 2306-2312.
4. Cohen HY., 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390-392.
5. Luo J, Nikolaev A, Imai S, et al. 2001. Negative control of p53 by Sir2 promotes cell survival under stress. Cell 107: 137-148.
6. Vaziri H, Dessain S, Eaton EN, et al. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
7. Motta M, Divecha N, Lemieux M, et al. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563.
8. Takayama K, Ishida K, Matsushita T, et al. 2009. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 60: 2731-2740.
9. Gagarina V, Gabay O, Dvir-Ginzberg M, et al. 2011. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing PTP1B and activating the IGF receptor pathway. Arthritis Rheum 63: 2363-2373.
10. Dvir-Ginzberg M, Gagarina V, Lee EJ, et al. 2008. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem 283: 36300-36310.
11. Fujita N, Matsushita T, Ishida K, et al. 2011. Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. J Orthop Res 29: 511-515.
12. Dvir-Ginzberg M, Gagarina V, Lee EJ, et al. 2011. Tumor necrosis factor α-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum 63: 2363-2373.
13. Gabay O, Oppenhiemer H, Meir H, et al. 2012. Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann Rheum Dis 71: 613-616.
14. Michishita E, Park JY, Burneskis JM, et al. 2005. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635.
15. Lauder SN, Carty SM, Carpenter CE, et al. 2007. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis. Rheumatology 46: 752-758.
16. Kevorkian L, Young DA, Darrah C, et al. 2004. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50: 131-141.
17. Little CB, Barai A, Burkhardt D, et al. 2009. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60: 3723-3733.
18. Verma P, Dalal K., 2011. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 112: 3507-3514.
19. Stanton H, Rogerson FM, East CJ, et al. 2005. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434: 648-652.
20. Glasson SS, Askew R, Sheppard B, et al. 2005. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434: 644-648.
21. Mengshol JA, Vincenti MP, Coon CI, et al. 2000. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43: 801-811.
22. Yeung F, Hoberg JE, Ramsey CS, et al. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380.
23. Chen L, Fischle W, Verdin E, et al. 2001. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653-1657.
24. Kiernan R, Bres V, Ng RW, et al. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-2766.
25. Shakibaei M, Csaki C, Nebrich S, et al. 2008. Resveratrol suppresses interleukin-1β-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76: 1426-1439.
26. Lei M, Wang JG, Xiao DM, et al. 2012. Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity. Eur J Pharmacol 674: 73-79.